[New viewpoints on the treatment of toxoplasmosis].
D000367:Age Factors; D002675:Child, Preschool; D003707:Demeclocycline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007933:Leucomycins / Q000627:therapeutic use; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D013443:Sulfisomidine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy
D007933:Leucomycins; D013411:Sulfadiazine; D013412:Sulfadimethoxine; D003707:Demeclocycline; D013421:Sulfamethoxypyridazine; D013443:Sulfisomidine; D011739:Pyrimethamine
Neuere Gesichtspunkte zur Behandlung der Toxoplasmose.